CUG2 Activators
CUG2 Activators represent a diverse group of chemical compounds that play a pivotal role in enhancing the functional activity of CUG2, a protein with multifaceted cellular functions. These activators operate through a range of well-defined mechanisms, each tailored to indirectly boost CUG2's activity. For instance, Forskolin elevates intracellular cAMP levels, subsequently activating protein kinase A (PKA), a key player in CUG2-related cellular processes.
Meanwhile, Genistein inhibits tyrosine kinases, reducing competition from tyrosine kinase signaling and allowing CUG2 pathways to flourish, enhancing its functional activity. This group also includes compounds like Sphingosine-1-phosphate and Thapsigargin, which modulate lipid and calcium signaling, respectively, indirectly potentiating cellular processes where CUG2 is involved, without affecting its expression or direct activation. PMA, Epigallocatechin, LY294002, Wortmannin, SB203580, U0126, A23187, and Staurosporine all contribute to CUG2 activation by either promoting CUG2-related pathways or reducing competitive signaling, ensuring that CUG2's vital functions are enhanced.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates CUG2 indirectly by elevating intracellular cAMP levels, which in turn activates protein kinase A (PKA) involved in CUG2-related cellular processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, reducing competition from tyrosine kinase signaling and allowing CUG2 pathways to be more active, thus enhancing its functional activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Modulates lipid signaling, indirectly potentiating cellular processes where CUG2 plays a role, without directly affecting CUG2 expression or activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Influences calcium signaling, indirectly enhancing CUG2-related cellular processes without affecting CUG2 expression or direct activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Acts as a PKC activator, promoting pathways associated with CUG2 and enhancing its functional activity without affecting CUG2 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Functions as a kinase inhibitor, contributing to CUG2 activation by reducing competition from survival signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that enhances CUG2 activity by reducing competition from PI3K-dependent signaling, promoting CUG2-related pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that indirectly enhances CUG2 function by reducing competition from PI3K-dependent signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, shifting the signaling equilibrium to favor pathways associated with CUG2, thereby enhancing its functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Enhances CUG2's activity by increasing intracellular calcium levels, activating calcium-dependent signaling pathways crucial for CUG2 functions. | ||||||